# Evidation Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evidation-health

- Industry: Healthcare IT
- Headquarters: San Mateo, US
- Website: www.evidation.com
- Total disclosed funding: $256M
- Latest round: Series E (Mar 5, 2021)
- Investors on record: 15

## About

Evidation Health, Inc. is a US-based company that leverages real-world health data to enhance health measurement and improvement, empowering individuals to engage in healthier behaviors through its innovative platform.Founded in 2012 and headquartered in San Mateo, US, Evidation Health, Inc. specializes in health data analytics and consumer engagement. The company was established by Alessio Signorini and Christine Lemke, who have experience in health technology. Evidation has successfully raised a total of USD 153.000 mn through 7 funding rounds, with the most recent being a Series E round on March 5, 2021, co-led by Kaiser Permanente Ventures and OMERS Private Equity, with total funding amounting to USD 153.000 mn, valuing the company at USD 890.036 mn.Evidation Health, Inc. offers a platform that utilizes real-world health data to enhance health measurement and improvement. Their core product is a mobile application that incentivizes users to adopt healthy behaviors like walking and exercising, allowing them to earn points for cash. This not only provides users with health insights but also contributes to health research. The platform serves approximately 5 million consumers in the US, aiding organizations in leveraging health data for research and interventions.Evidation Health, Inc. generates revenue through partnerships with research entities and health organizations that utilize the aggregated health data collected from users. The company engages in direct-to-consumer transactions, rewarding user participation through a points system to foster ongoing engagement and data sharing. Although specific pricing plans have not been disclosed, the operations emphasize user data protection and personalized health insights.Following the Series E funding round in March 2021, Evidation Health, Inc. plans to accelerate the expansion of its virtual health programs. This funding of USD 153.000 mn, which values the company at USD 1 billion post-money, will be utilized to enhance their platform's offerings. The company aims to expand its services into new geographic markets, although specific regions have yet to be detailed. CEO Deborah Kilpatrick will continue to lead Evidation as it focuses on growing its user base and health data contributions.

## Funding rounds

- Series E, Mar 5, 2021, $153M — OMERS Private Equity, Kaiser Permanente Ventures, McKesson Ventures, B Capital
- Series D, Apr 15, 2020, $45M — SV Health Investors, Rethink Capital Partners, McKesson Ventures, Revelation Partners, B Capital, Section 32
- Series C, Apr 20, 2018, $30M — SV Health Investors, Sanofi Ventures, B Capital, GE Ventures
- Series B, Apr 11, 2017, $10M — Sanofi Ventures, B Capital, GE Ventures
- Series B, May 25, 2016, $12M — Pappas Capital, Asset Management Ventures, Fresco Capital, B Capital, GE Ventures
- Series A, Dec 31, 2014, $6.2M — GE Capital, Equity, Asset Management Ventures, Rock Health, Fresco Capital
- Seed, Jun 13, 2013 — Asset Management Ventures

## Investors

- Asset Management Ventures (https://capitalatlas.ai/funds/asset-management-ventures) — Seed, Series A, Series B
- GE Capital, Equity (https://capitalatlas.ai/funds/ge-capital-equity) — Series A
- Rock Health (https://capitalatlas.ai/funds/rock-health) — Series A
- Fresco Capital — Series A, Series B
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series B
- B Capital (https://capitalatlas.ai/funds/b-capital) — Series B, Series C, Series D, Series E
- GE Ventures — Series B, Series C
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series B, Series C
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series C, Series D
- Rethink Capital Partners (https://capitalatlas.ai/funds/rethink-capital-partners) — Series D
- McKesson Ventures (https://capitalatlas.ai/funds/mckesson-ventures) — Series D, Series E
- Revelation Partners (https://capitalatlas.ai/funds/revelation-partners) — Series D
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series D
- OMERS Private Equity (https://capitalatlas.ai/funds/omers-private-equity) — Series E
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series E